Proglumide ( DrugBank: Proglumide )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
298遺伝性膵炎1

298. 遺伝性膵炎


臨床試験数 : 95 薬物数 : 148 - (DrugBank : 51) / 標的遺伝子数 : 53 - 標的パスウェイ数 : 142
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05551858
(ClinicalTrials.gov)
November 17, 20221/9/2022Role of a CCK Receptor Antagonist Proglumide in Management of Chronic PancreatitisA Phase 1/2 Trial to Test the Safety of a CCK Receptor Antagonist, Proglumide, in Management of Chronic Pancreatitis Symptoms and Pain for 12 to 24 MonthsSafety Issues;Pain;Pancreas FibrosisDrug: Proglumide;Drug: PlaceboGeorgetown UniversityNULLRecruiting18 Years75 YearsAll32Phase 1/Phase 2United States